Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

Weight-loss drugs like Wegovy and Zepbound are transforming the health of millions of people—and a new study hints that even more could benefit from the drugs’ other effects on the body. A study ...

From meditation to molecular science, addiction treatment is being reinvented. See how new breakthroughs are giving hope for recovery.

We need a new paradigm for addiction that puts psychology first and recognizes its heterogeneity. Only then will we see that ...

Much of the conversation around addiction swings between two worldviews. On one side is the belief that addiction is a brain ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Dr. Harriet de Wit's groundbreaking 45-year journey bridges animal and human drug research, reshaping global understanding of consciousness CHICAGO, Illinois, USA, 26 August 2025 -- In a revealing ...

Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and ...

Share on Pinterest A growing body of evidence suggests that GLP-1 drugs prescribed for obesity and diabetes could also help treat addiction. FreshSplash/Getty Images GLP-1 drugs like Ozempic and ...

Where does opium come from? The opium poppy grows best in warm, dry climates. Most opium is grown in a long, narrow stretch of mountains in central Asia, an area that starts in Turkey and moves east ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier ...

MIAMI, FL / ACCESS Newswire / July 11, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) today announced new preclinical results from SKNY-1, an oral drug candidate for obesity and nicotine addiction ...